Evidence map›Paper›PMID 24057816›Full record

ArticlePsychopharmacology2014

Behavioral effects of dopamine receptor inactivation in the caudate-putamen of preweanling rats: role of the D2 receptor.

Taleen Der-Ghazarian, Crystal B Widarma, Arnold Gutierrez, Leslie R Amodeo, Joseph M Valentine, Danielle E Humphrey, Ashley E Gonzalez, Cynthia A Crawford, Sanders A McDougall

Abstract read
In one paragraph

Article in Psychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Dopamine DThe Journal of pharmacology and experimental therapeutics · 2018
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Taleen Der-GhazarianDepartment of Psychology, California State University, 5500 University Parkway, San Bernardino, CA, 92407, USA.
Crystal B Widarma
Arnold Gutierrez
Leslie R Amodeo
Joseph M Valentine
Danielle E Humphrey
Ashley E Gonzalez
Cynthia A Crawford
Sanders A McDougall

Funding

TRAINING PROGRAM IN TERATOLOGYT32ES007051 · NIEHS · CINCINNATI CHILDRENS HOSP MED CTR · PI VORHEES, CHARLES V · 1985 to 2018
$4.1M
CSU San Bernardino Minority Access to Research CareersT34GM083883 · NIGMS · CALIFORNIA STATE UNIV SAN BERNARDINO · PI MCDOUGALL, SANDERS · 2009 to 2019
$3.0M
Ontogeny of caudate-putamen functioning: behavioral relevanceSC1MH102930 · NIMH · CALIFORNIA STATE UNIV SAN BERNARDINO · PI MCDOUGALL, SANDERS · 2013 to 2016
$1.4M
CSUSB Minority Drug Abuse Research ProgramR24DA025319 · NIDA · CALIFORNIA STATE UNIV SAN BERNARDINO · PI CRAWFORD, CYNTHIA A. · 2009 to 2010
$852k
NIDA NIH HHS DA025319NIDA NIH HHS R24 DA025319NIEHS NIH HHS T32 ES007051NIGMS NIH HHS GM083883NIGMS NIH HHS T34 GM083883NIMH NIH HHS MH102930NIMH NIH HHS SC1 MH102930
6 · The paper itself

Abstract

rationaleInactivating dopamine (DA) receptors in the caudate-putamen (CPu) attenuates basal and DA agonist-induced behaviors of adult rats while paradoxically increasing the locomotor activity of preweanling rats.

objectiveThe purpose of this study was to determine (a) whether D1 or D2 receptor inactivation is responsible for the elevated locomotion shown by preweanling rats and (b) whether DA receptor inactivation produces a general state in which any locomotor-activating drug will cause a potentiated behavioral response.

methodsDimethyl sulfoxide (DMSO) or N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) was bilaterally infused into the CPu on postnatal day (PD) 17. In experiment 1, DA receptors were selectively protected from EEDQ-induced alkylation by pretreating rats with D1 and/or D2 antagonists. On PD 18, rats received bilateral microinjections of the DA agonist R(-)-propylnorapomorphine into the dorsal CPu, and locomotor activity was measured for 40 min. In subsequent experiments, the locomotion of DMSO- and EEDQ-pretreated rats was assessed after intraCPu infusions of the selective DA agonists SKF82958 and quinpirole, the partial agonist terguride, or after systemic administration of nonDAergic compounds.

resultsExperiment 1 showed that EEDQ's ability to enhance the locomotor activity of preweanling rats was primarily due to the inactivation of D2 receptors. Consistent with this finding, only drugs that directly or indirectly stimulated D2 receptors produced a potentiated locomotor response in EEDQ-treated rats.

conclusionsThese results show that DA receptor inactivation causes dramatically different behavioral effects in preweanling and adult rats, thus providing additional evidence that the D2 receptor system is not functionally mature by the end of the preweanling period.

Indexed as

AgingAlkylating AgentsAnimalsApomorphineBenzazepinesCaudate NucleusDimethyl SulfoxideDopamine AgonistsDopamine AntagonistsDopamine D2 Receptor AntagonistsFemaleLisurideMaleMotor ActivityPutamenQuinolinesAlkylating AgentsApomorphineBenzazepinesDimethyl SulfoxidedironylDopamine AgonistsDopamine AntagonistsDopamine D2 Receptor AntagonistsEEDQLisurideN-n-propylnorapomorphineQuinolinesQuinpiroleReceptors, Dopamine D1Receptors, Dopamine D2SK&F 82958

Identifiers

PMID24057816
PMCPMC3946740

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.